Mayer-Rokitansky-Küster-Hauser syndrome: a review of 245 consecutive cases managed by a multidisciplinary approach with vaginal dilators

Mayer-Rokitansky-Kuster-Hauser syndrome management by a multidisciplinary approach, including psychologists, results in no need for surgical intervention.

Like Comment


D. Keith Edmonds, F.R.C.O.G., Gillian L. Rose, F.R.C.O.G., Michelle G. Lipton, D.Clin.Psy., Julie Quek, R.N.

Volume 97, Issue 3, Pages 686-690



To understand the efficacy of vaginal dilators in the management of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.


Retrospective sequential study.




245 women.


Vaginal dilators.

Main Outcome Measure(s):

Functional vaginal length and sexual satisfaction.


Of the patients who completed the program, 232 (94.9%) achieved a successful vaginal length (defined as greater than 6 cm in length and maximum width throughout the vagina and especially at the apex) and sexual function. When the program was completed by all patients, 100% of patients were successful.


Vaginal dilator therapy is the treatment of first choice for creation of the vagina in MRKH syndrome, and the success rates suggest that surgery is rarely, if ever, required.

Read the full text at:

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.